Evidence map›Paper›PMID 29359962›Full record

ReviewBiopreservation and biobanking2018

Enhancing Reuse of Data and Biological Material in Medical Research: From FAIR to FAIR-Health.

Petr Holub, Florian Kohlmayer, Fabian Prasser, Michaela Th Mayrhofer, Irene Schlünder, Gillian M Martin, Sara Casati, Lefteris Koumakis, Andrea Wutte, Łukasz Kozera and 11 more

Abstract readReview
In one paragraph

Review in Biopreservation and biobanking, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Petr Holub1 BBMRI-ERIC , Graz, Austria .
Florian Kohlmayer2 Technical University of Munich , Munich, Germany .
Fabian Prasser2 Technical University of Munich , Munich, Germany .
Michaela Th Mayrhofer1 BBMRI-ERIC , Graz, Austria .
Irene Schlünder1 BBMRI-ERIC , Graz, Austria .
Gillian M Martin4 BBMRI.mt and University of Malta , Msida, Malta .
Sara Casati5 BBMRI.it and Universita degli Studi di Milano-Bicocca , Milano, Italy .
Lefteris Koumakis6 BBMRI.gr and Foundation for Research and Technology-Hellas , Heraklion, Greece .
Andrea Wutte1 BBMRI-ERIC , Graz, Austria .
Łukasz Kozera7 BBMRI.pl and Wroclaw Research Centre EIT+ , Wroclaw, Poland .
Dominik Strapagiel8 BBMRI.pl and University of Łódź , Łódź, Poland .
Gabriele Anton9 Helmholtz Zentrum München , Munich, Germany .
Gianluigi Zanetti10 BBMRI.it and CRS4 , Pula, Italy .
Osman Ugur Sezerman11 BBMRI.tr and Acibadem University , Istanbul, Turkey .
Maimuna Mendy12 BBMRI.IARC and International Agency for Research on Cancer , Lyon, France .
Dalibor Valík13 BBMRI.cz and Masaryk Memorial Cancer Institute , Brno, Czech Republic .
Marialuisa Lavitrano5 BBMRI.it and Universita degli Studi di Milano-Bicocca , Milano, Italy .
Georges Dagher14 INSERM , Paris, France .
Kurt Zatloukal15 BBMRI.at and Medical University Graz , Graz, Austria .
GertJan B van Ommen16 BBMRI.nl and Leiden University Medical Center , Leiden, Netherlands .
Jan-Eric Litton1 BBMRI-ERIC , Graz, Austria .

Funding

World Health Organization 001
6 · The paper itself

Abstract

The known challenge of underutilization of data and biological material from biorepositories as potential resources for medical research has been the focus of discussion for over a decade. Recently developed guidelines for improved data availability and reusability-entitled FAIR Principles (Findability, Accessibility, Interoperability, and Reusability)-are likely to address only parts of the problem. In this article, we argue that biological material and data should be viewed as a unified resource. This approach would facilitate access to complete provenance information, which is a prerequisite for reproducibility and meaningful integration of the data. A unified view also allows for optimization of long-term storage strategies, as demonstrated in the case of biobanks. We propose an extension of the FAIR Principles to include the following additional components: (1) quality aspects related to research reproducibility and meaningful reuse of the data, (2) incentives to stimulate effective enrichment of data sets and biological material collections and its reuse on all levels, and (3) privacy-respecting approaches for working with the human material and data. These FAIR-Health principles should then be applied to both the biological material and data. We also propose the development of common guidelines for cloud architectures, due to the unprecedented growth of volume and breadth of medical data generation, as well as the associated need to process the data efficiently.

Indexed as

Biological Specimen BanksConfidentialityDatabases, FactualGuidelines as TopicHumansInformation DisseminationFAIR (Findable, Accessible, Interoperable, and Reusable) principlesincentivesopen scienceprivacy protectionprovenance information managementquality

Identifiers

PMID29359962
PMCPMC5906729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.